Imunon (IMNN) Set to Announce Quarterly Earnings on Thursday

Imunon (NASDAQ:IMNN) is scheduled to be announcing its earnings results before the market opens on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.37) per share for the quarter.

Imunon (NASDAQ:IMNN) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.51) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.55) by $0.04. On average, analysts expect Imunon to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Imunon Stock Up 1.1 %

Imunon stock traded up $0.01 during midday trading on Tuesday, hitting $0.99. 198,227 shares of the company were exchanged, compared to its average volume of 993,945. Imunon has a fifty-two week low of $0.48 and a fifty-two week high of $3.65. The business has a fifty day simple moving average of $1.03 and a two-hundred day simple moving average of $1.21.

Analysts Set New Price Targets

Several analysts recently commented on IMNN shares. HC Wainwright restated a “buy” rating and set a $14.00 price target on shares of Imunon in a research report on Thursday, August 15th. EF Hutton Acquisition Co. I upgraded shares of Imunon to a “strong-buy” rating in a research report on Monday, September 23rd.

About Imunon

Imunon, Inc, a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company’s lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development.